Press Releases Year None20212020201920182017 February 25, 2021 SpringWorks Therapeutics Reports Interim Data from Phase 2b ReNeu Trial of Mirdametinib for Patients with NF1-PN and Provides Trial Update PDF Version February 22, 2021 SpringWorks Therapeutics to Present at Upcoming Investor Conferences PDF Version February 4, 2021 SpringWorks Therapeutics to Present at the Guggenheim Healthcare Talks 2021 Oncology Day PDF Version January 5, 2021 SpringWorks Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference PDF Version December 15, 2020 SpringWorks Therapeutics Announces Executive Leadership Promotions PDF Version November 24, 2020 SpringWorks Therapeutics to Participate in the Evercore ISI HealthCONx Conference PDF Version November 12, 2020 SpringWorks Therapeutics Reports Third Quarter 2020 Financial Results and Recent Business Highlights PDF Version October 26, 2020 Jazz Pharmaceuticals Acquires SpringWorks Therapeutics’ FAAH Inhibitor Program PDF Version October 13, 2020 SpringWorks Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares PDF Version October 7, 2020 SpringWorks Therapeutics Announces Pricing of Public Offering of Common Stock PDF Version Pagination First page « first Previous page ‹ previous Page 1 Page 2 Current page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Next page next › Last page last »
February 25, 2021 SpringWorks Therapeutics Reports Interim Data from Phase 2b ReNeu Trial of Mirdametinib for Patients with NF1-PN and Provides Trial Update PDF Version
February 4, 2021 SpringWorks Therapeutics to Present at the Guggenheim Healthcare Talks 2021 Oncology Day PDF Version
January 5, 2021 SpringWorks Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference PDF Version
November 24, 2020 SpringWorks Therapeutics to Participate in the Evercore ISI HealthCONx Conference PDF Version
November 12, 2020 SpringWorks Therapeutics Reports Third Quarter 2020 Financial Results and Recent Business Highlights PDF Version
October 26, 2020 Jazz Pharmaceuticals Acquires SpringWorks Therapeutics’ FAAH Inhibitor Program PDF Version
October 13, 2020 SpringWorks Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares PDF Version
October 7, 2020 SpringWorks Therapeutics Announces Pricing of Public Offering of Common Stock PDF Version
